Skip to main content
SpringerLink
Log in

Computational Screening Techniques for Lead Design and Development

  • Chapter
  • First Online:
Computer-Aided Drug Design

Abstract

Virtual screening is a computational screening technique used to screen drug-like compounds from vast libraries of chemicals based on the binding energy of compounds with a target. To discover new plausible drug candidates, computational chemistry tools are used for studying the absorption, distribution, metabolism, excretion, and toxicity (ADMET) of potential drugs, as well as also decipher the mechanisms of drug action and its interaction mode with the target. Many drug designing tools are available, which can assist in the design and discovery of new drugs for the treatment of diseases with fewer or no side effects. The objective is to evaluate several millions of compounds saving time and cost of discovery. The quantitative structure-activity relationship (QSAR) analysis has made it possible to theoretically correlate the biological activity of a compound with its physicochemical properties, and the predictive equation has been derived for the assessment of the biological response of a compound using molecular descriptors. Bioinformatics and Cheminformatics database in houses several million of compounds with similar architecture and biological properties. Screening and identification of potential candidates for the appropriate term and target is a difficult mining task in terms of cost and time. Virtual screening tools developed by various bioinformatics and cheminformatics groups are contributing to the field of open source drug discovery project. Online computational resources in drug discovery research are a helping hand to the community, with remote and free access to the resources.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Acker MG, Auld DS (2014) Considerations for the design and reporting of enzyme assays in high-throughput screening applications. Perspect Sci 1:56–73

    Article  Google Scholar 

  • Akagah B, Lormier AT, Fournet A, Figadère B (2008) Oxidation of antiparasitic 2-substituted quinolines using metalloporphyrin catalysts: scale-up of a biomimetic reaction for metabolite production of drug candidates. Org Biomol Chem 6:4494–4497

    Article  CAS  PubMed  Google Scholar 

  • Alqahtani S (2017) In silico ADME-Tox modeling: progress and prospects. Expert Opin Drug Metab Toxicol 13:1147–1158

    Article  CAS  PubMed  Google Scholar 

  • Arnott JA, Planey SL (2012) The influence of lipophilicity in drug discovery and design. Expert Opin Drug Discovery 7:863–875

    Article  CAS  Google Scholar 

  • Ashby J, Tennant RW (1988) Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. Mutat Res 204:17–115

    Article  CAS  PubMed  Google Scholar 

  • Balakin KV, Ivanenkov YA, Savchuk NP, Ivashchenko AA, Ekins S (2005) Comprehensive computational assessment of ADME properties using mapping techniques. Curr Drug Discov Technol 2:99–113

    Article  CAS  PubMed  Google Scholar 

  • Beckett BS (1987) Biology: a modern introduction. Oxford University Press, Oxford

    Google Scholar 

  • Benigni R, Bossaa C, Jeliazkovab N, Netzevac T, Worthc A (2008) The Benigni/Bossa rulebase for mutagenicity and carcinogenicity – a module of Toxtree. https://ec.europa.eu/jrc/en/publication/eur-scientific-and-technical-research-reports/benigni-bossa-rulebase-mutagenicity-and-carcinogenicity-module-toxtree. Accessed May 2020

  • Berggren E, Amcoff P, Benigni R, Blackburn K, Carney E, Cronin M, Deluyker H et al (2015) Chemical safety assessment using read-across: assessing the use of novel testing methods to strengthen the evidence base for decision making. Environ Health Perspect 123:1232–1240

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bergström CAS, Larsson P (2018) Computational prediction of drug solubility in water-based systems: qualitative and quantitative approaches used in the current drug discovery and development setting. Int J Pharm 540:185–193

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Bocci G, Carosati E, Vayer P, Arrault A, Lozano S, Cruciani G (2017) ADME-space: a new tool for medicinal chemists to explore ADME properties. Sci Rep 7:6359

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Botham PA, Hayes AW, Moir D (2002) The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for acute local skin and eye toxicity testing. ILAR J 43(Suppl):S105–S107

    Article  CAS  PubMed  Google Scholar 

  • Broach JR, Thorner J (1996) High-throughput screening for drug discovery. Nature 384(6604 Suppl):14–16

    CAS  PubMed  Google Scholar 

  • Carnero A (2006) High throughput screening in drug discovery. Clin Transl Oncol 8:482–490

    Article  CAS  PubMed  Google Scholar 

  • Caruthers JM, Lauterbach JA, Thomson KT, Venkatasubramanian V, Snively CM, Bhan A, Katare S, Oskarsdottir G (2003) Catalyst design: knowledge extraction from high-throughput experimentation. J Catal 216:98–109

    Article  CAS  Google Scholar 

  • Cocucci E, Kim JY, Bai Y, Pabla N (2017) Role of passive diffusion, transporters, and membrane trafficking-mediated processes in cellular drug transport. Clin Pharmacol Ther 101:121–129

    Article  CAS  PubMed  Google Scholar 

  • Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959–5967

    Article  CAS  PubMed  Google Scholar 

  • Czarnik AW, Mei HY (2007) How and why to apply the latest technology. In: Comprehensive medicinal chemistry II. Elsevier, Amsterdam, pp 289–557

    Chapter  Google Scholar 

  • Daina A, Zoete V (2016) A BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 11:1117–1121

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717

    Article  PubMed  PubMed Central  Google Scholar 

  • Damale MG, Harke SN, Kalam Khan FA, Shinde DB, Sangshetti JN (2014) Recent advances in multidimensional QSAR (4D-6D): a critical review. Mini Rev Med Chem 14:35–55

    Article  CAS  PubMed  Google Scholar 

  • Du G, Fang Q, den Toonder JMJ (2016) Microfluidics for cell-based high throughput screening platforms - a review. Anal Chim Acta 903:36–50

    Article  CAS  PubMed  Google Scholar 

  • Ducki S, Mackenzie G, Lawrence NJ, Snyder JP (2005) Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly. J Med Chem 48:457–465

    Article  CAS  PubMed  Google Scholar 

  • Egan WJ, Merz KM, Baldwin JJ (2000) Prediction of drug absorption using multivariate statistics. J Med Chem 43:3867–3877

    Article  CAS  PubMed  Google Scholar 

  • Everitt BS, Dunn G (1992) Applied multivariate data analysis. Oxford University Press, London

    Google Scholar 

  • Fisher RA (1936) The use of multiple measurements in taxonomic problems. Ann Eugenics 7:179–188

    Article  Google Scholar 

  • Fritsche E, Crofton KM, Hernandez AF, Hougaard Bennekou S, Leist M, Bal-Price A, Reaves E et al (2017) OECD/EFSA workshop on developmental neurotoxicity (DNT): the use of non-animal test methods for regulatory purposes. ALTEX 34:311–315

    Article  PubMed  Google Scholar 

  • Ghose AK, Viswanadhan VN, Wendoloski JJ (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1:55–68

    Article  CAS  PubMed  Google Scholar 

  • Glickman JF, Schmid A, Ferrand S (2008) Scintillation proximity assays in high-throughput screening. Assay Drug Dev Technol 6:433–455

    Article  CAS  PubMed  Google Scholar 

  • Gramatica P (2013) On the development and validation of QSAR models. Methods Mol Biol 930:499–526

    Article  CAS  PubMed  Google Scholar 

  • Guengerich FP (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 14:611–650

    Article  CAS  PubMed  Google Scholar 

  • Gupta PP, Bastikar VA, Kuciauskas D, Kothari SL, Cicenas J, Valius M (2017) Molecular modeling and structure-based drug discovery approach reveals protein kinases as off-targets for novel anticancer drug RH1. Med Oncol 34:176

    Article  PubMed  CAS  Google Scholar 

  • Hann MM, Oprea TI (2004) Pursuing the leadlikeness concept in pharmaceutical research. Curr Opin Chem Biol 8:255–263

    Article  CAS  PubMed  Google Scholar 

  • Hansch C (1969) Quantitative approach to biochemical structure-activity relationships. Acc Chem Res 2:232–239

    Article  CAS  Google Scholar 

  • Huang SM, Strong JM, Zhang L, Reynolds KS, Nallani S, Temple R, Abraham S et al (2008) New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process. J Clin Pharmacol 48:662–670

    Article  CAS  PubMed  Google Scholar 

  • Jenkinson DH (1991) Principles of drug action, the basis of pharmacology (3rd edn). Trends Pharmacol Sci 12:77–78

    Article  Google Scholar 

  • Kirchmair J, Göller AH, Lang D, Kunze J, Testa B, Wilson ID, Glen RC, Schneider G (2015) Predicting drug metabolism: experiment and/or computation? Nat Rev Drug Discov 14:387–404

    Article  CAS  PubMed  Google Scholar 

  • Kriegel H, Kröger P, Sander J, Zimek A (2011) Density-based clustering. WIREs Data Min Knowl Discovery 1:231–240

    Article  Google Scholar 

  • Kubinyi H (1988) Free Wilson analysis. Theory, applications and its relationship to Hansch analysis. Quant Struct-Act Relat 7:121–133

    Article  CAS  Google Scholar 

  • Li Pira G, Ivaldi F, Moretti P, Manca F (2010) High throughput T epitope mapping and vaccine development. J Biomed Biotechnol 2010:325720

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3–26

    Article  CAS  PubMed  Google Scholar 

  • Liu B, Li S, Hu J (2004) Technological advances in high-throughput screening. Am J Pharmacogenomics 4:263–276

    Article  CAS  PubMed  Google Scholar 

  • Liu L, Yang H, Lou Y, Wu JY, Miao J, Lu XY, Gao JQ (2019) Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles. Int J Pharm 557:170–177

    Article  CAS  PubMed  Google Scholar 

  • Mahfouz NM, Omar FA, Aboul-Fadl T (1999) Cyclic amide derivatives as potential prodrugs II: N-hydroxymethylsuccinimide-/isatin esters of some NSAIDs as prodrugs with an improved therapeutic index. Eur J Med Chem 34:551–562

    CAS  PubMed  Google Scholar 

  • Mannhold R, Poda GI, Ostermann C, Tetko IV (2009) Calculation of molecular lipophilicity: state-of-the-art and comparison of log P methods on more than 96,000 compounds. J Pharm Sci 98:861–893

    Article  CAS  PubMed  Google Scholar 

  • Mayr LM, Bojanic D (2009) Novel trends in high-throughput screening. Curr Opin Pharmacol 9:580–588

    Article  CAS  PubMed  Google Scholar 

  • McNaughton R, Huet G, Shakir S (2014) An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision-making. BMJ Open 4:e004221

    Article  PubMed  PubMed Central  Google Scholar 

  • Michael S, Auld D, Klumpp C, Jadhav A, Zheng W, Thorne N, Austin CP, Inglese J, Simeonov A (2008) A robotic platform for quantitative high-throughput screening. Assay Drug Dev Technol 6:637–657

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Milstein R, Schreyoegg J (2016) Pay for performance in the inpatient sector: a review of 34 P4P programs in 14 OECD countries. Health Policy 120:1125–1140

    Article  PubMed  Google Scholar 

  • Montanari F, Ecker GF (2015) Prediction of drug-ABC-transporter interaction—recent advances and future challenges. Adv Drug Deliv Rev 86:17–26

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Morales AH, Pérez MAC, Combes RD, González MP (2006) Quantitative structure activity relationship for the computational prediction of nitrocompounds carcinogenicity. Toxicology 220:51–62

    Article  PubMed  CAS  Google Scholar 

  • Morya VK, Kumari S, Kim EK (2012) Virtual screening and evaluation of Ketol-Acid Reducto-Isomerase (KARI) as a putative drug target for Aspergillosis. Clin Proteomics 9:1

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Muegge I, Heald SL, Brittelli D (2001) Simple selection criteria for drug-like chemical matter. J Med Chem 44:1841–1846

    Article  CAS  PubMed  Google Scholar 

  • Ottaviani G, Gosling DJ, Patissier C, Rodde S, Zhou L, Faller B (2010) What is modulating solubility in simulated intestinal fluids? Eur J Pharm Sci 41:452–457

    Article  CAS  PubMed  Google Scholar 

  • Parkinson EI, Bair JS, Cismesia M, Hergenrother PJ (2013) Efficient NQO1 substrates are potent and selective anticancer agents. ACS Chem Biol 8:2173–2183

    Article  CAS  PubMed  Google Scholar 

  • Pavan M (2013) Factors affecting drug distribution. http://www.authorstream.com/Presentation/murari33pavan-971247-factors-affecting-d-murari/. Accessed 10 Jan 2019

  • Payne MP, Walsh PT (1994) Structure-activity relationships for skin sensitization potential: development of structural alerts for use in knowledge-based toxicity prediction systems. J Chem Inf Comput Sci 34:154–161

    Article  CAS  PubMed  Google Scholar 

  • Plošnik A, Vračko M, Dolenc MS (2016) Mutagenic and carcinogenic structural alerts and their mechanisms of action. Arh Hig Rada Toksikol 67:169–182

    Article  PubMed  CAS  Google Scholar 

  • Pratt WB, Taylor P, Goldstein A (1990) In: Pratt WB, Taylor P (eds) Principles of drug action: the basis of pharmacology, 3rd edn. Churchill Livingstone, New York

    Google Scholar 

  • Prentis R, Lis Y, Walker S (1988) Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). Br J Clin Pharmacol 25:387–396

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Raies AB, Bajic VB (2016) In silico toxicology: computational methods for the prediction of chemical toxicity. Wiley Interdiscip Rev Comput Mol Sci 6:147–172

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Richard AM, Yang C, Judson RS (2008) Toxicity data informatics: supporting a new paradigm for toxicity prediction. Toxicol Mech Methods 18:103–118

    Article  CAS  PubMed  Google Scholar 

  • Ritchie TJ, Macdonald SJF, Peace S, Pickett SD, Luscombe CN (2013) Increasing small molecule drug developability in sub-optimal chemical space. Med Chem Commun 4:673

    Article  CAS  Google Scholar 

  • Roy K, Das RN (2014) A review on principles, theory and practices of 2D-QSAR. Curr Drug Metab 15:346–379

    Article  CAS  PubMed  Google Scholar 

  • Roy K, Kar S, Das RN (2015) A primer on QSAR/QSPR modeling. Springer, Cham

    Book  Google Scholar 

  • Sakuratani Y, Horie M, Leinala E (2018) Integrated approaches to testing and assessment: OECD activities on the development and use of adverse outcome pathways and case studies. Basic Clin Pharmacol Toxicol 123(Suppl):20–28

    Article  CAS  PubMed  Google Scholar 

  • Sanches BMA, Ferreira EI (2019) Is prodrug design an approach to increase water solubility? Int J Pharm 568:118498

    Article  CAS  PubMed  Google Scholar 

  • Savjani KT, Gajjar AK, Savjani JK (2012) Drug solubility: importance and enhancement techniques. ISRN Pharm 2012:1–10

    Google Scholar 

  • Schlichting I, Berendzen J, Chu K, Stock AM, Maves SA, Benson DE, Sweet RM, Ringe D, Petsko GA, Sligar SG (2000) The catalytic pathway of cytochrome p450cam at atomic resolution. Science 287:1615–1622

    Article  CAS  PubMed  Google Scholar 

  • Schroeder R (2018) Where are lipids located in the body? https://sciencing.com/lipids-located-body-5387939.html. Accessed 27 Dec 2018

  • Schuster D, Laggner C, Langer T (2005) Why drugs fail - a study on side effects in new chemical entities. Curr Pharm Des 11:3545–3559

    Article  CAS  PubMed  Google Scholar 

  • Sharma HL, Sharma KK (2011) What is ion trapping? (Pharmacology). http://prosciencepharma.blogspot.com/2011/10/what-is-ion-trapping-pharmacology.html. Accessed 29 Jan 2019

  • Sharom FJ (2008) ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 9:105–127

    Article  CAS  PubMed  Google Scholar 

  • Shaw PJA (2003) Multivariate statistics for the environmental sciences. Oxford University Press, London

    Google Scholar 

  • Shore PA, Brodie BB, Hobgen CA (1957) The gastric secretion of drugs: a pH partition hypothesis. J Pharmacol Exp Ther 119:361–369

    CAS  PubMed  Google Scholar 

  • Singh DB (2018) Natural lead compounds and strategies for optimization. In: Ul-Haq Z, Wilson AK (eds) Frontiers in computational chemistry. Bentham Science, Sharjah, pp 1–47

    Google Scholar 

  • Singh DB, Dwivedi S (2019) Computational screening and ADMET-based study for targeting Plasmodium S-adenosyl-L-homocysteine hydrolase: top scoring inhibitors. Netw Model Anal Health Inform Bioinform 8:4

    Article  Google Scholar 

  • Singh S, Malik BK, Sharma DK (2006) Molecular drug targets and structure based drug design: a holistic approach. Bioinformation 1:314–320

    Article  PubMed  PubMed Central  Google Scholar 

  • Sliwoski G, Kothiwale S, Meiler J, Lowe EW (2014) Computational methods in drug discovery. Pharmacol Rev 66:334–395

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Stephens ML (2010) An animal protection perspective on 21st century toxicology. J Toxicol Environ Health B Crit Rev 13:291–298

    Article  CAS  PubMed  Google Scholar 

  • Stoner CL, Troutman MD, Laverty CE (2008) Pharmacokinetics and ADME optimization in drug discovery. In: Cancer drug design and discovery. Academic Press, New York, pp 131–153

    Chapter  Google Scholar 

  • Szakács G, Váradi A, Ozvegy-Laczka C, Sarkadi B (2008) The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discov Today 13:379–393

    Article  PubMed  CAS  Google Scholar 

  • Tate J, Ward G (2004) Interferences in immunoassay. Clin Biochem Rev 25:105–120

    PubMed  PubMed Central  Google Scholar 

  • Testa B, Krämer SD (2007) The biochemistry of drug metabolism – an introduction. Chem Biodivers 4:2031–2122

    Article  CAS  PubMed  Google Scholar 

  • Thomas G (2007) CH5 combinatorial chemistry. In: Medicinal chemistry: an introduction. Wiley, Chichester, p 170

    Google Scholar 

  • Thomas G (2008) Medicinal chemistry: an introduction, 2nd edn. Wiley, Chichester

    Google Scholar 

  • Tropsha A (2010) Best practices for QSAR model development, validation, and exploitation. Mol Inf 29:476–488

    Article  CAS  Google Scholar 

  • Vallianatou T, Giaginis C, Tsantili-Kakoulidou A (2015) The impact of physicochemical and molecular properties in drug design: navigation in the “drug-like” chemical space. Adv Exp Med Biol 822:187–194

    Article  CAS  PubMed  Google Scholar 

  • Van de Waterbeemd H, Testa B (2007) The why and how of absorption, distribution, metabolism, excretion, and toxicity research. In: Comprehensive medicinal chemistry II. Elsevier, Amsterdam, pp 1–9

    Google Scholar 

  • van Waterschoot RAB, Schinkel AH (2011) A critical analysis of the interplay between cytochrome P450 3A and P-glycoprotein: recent insights from knockout and transgenic mice. Pharmacol Rev 63:390–410

    Article  PubMed  CAS  Google Scholar 

  • Vasavid P, Chaiwatanarat T, Pusuwan P, Sritara C, Roysri K, Namwongprom S, Kuanrakcharoen P et al (2014) Normal solid gastric emptying values measured by scintigraphy using Asian-style meal: a multicenter study in healthy volunteers. J Neurogastroenterol Motil 20:371–378

    Article  PubMed  PubMed Central  Google Scholar 

  • Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615–2623

    Article  CAS  PubMed  Google Scholar 

  • Veith H, Southall N, Huang R, James T, Fayne D, Artemenko N, Shen M et al (2009) Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries. Nat Biotechnol 27:1050–1055

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Verma J, Khedkar VM, Coutinho EC (2010) 3D-QSAR in drug design—a review. Curr Top Med Chem 10:95–115

    Article  CAS  PubMed  Google Scholar 

  • Virupaksha B, Alpana G (2012) CoMFA QSAR models of camptothecin analogues based on the distinctive SAR features of combined ABC, CD and E ring substitutions. Comput Biol Med 42:890–897

    Article  CAS  PubMed  Google Scholar 

  • Wildey MJ, Haunso A, Tudor M, Webb M, Connick JH (2017) High-throughput screening. In: Annual reports in medicinal chemistry. Elsevier, Amsterdam, pp 149–195

    Google Scholar 

  • Wolf CR, Smith G, Smith RL (2000) Science, medicine, and the future: pharmacogenetics. BMJ 320:987–990

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yang H, Lou C, Sun L, Li J, Cai Y, Wang Z, Li W, Liu G, Tang Y (2018) admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics 35(6):1067–1069

    Article  CAS  Google Scholar 

  • Zhong Y, Guo Z, Che J (2015) Data quality assurance and statistical analysis of high throughput screenings for drug discovery. In: Frontiers in computational chemistry. Bentham Science Publishers, Sharjah, pp 389–425

    Google Scholar 

Download references

Competing Interest

The authors declare that there are no competing interests.

Author information

Authors and Affiliations

  1. School of Biotechnology and Bioinformatics, D Y Patil Deemed to be University, Navi Mumbai, Maharashtra, India

    Pramodkumar P. Gupta

  2. Amity Institute of Biotechnology, Amity University, Mumbai, Maharashtra, India

    Virupaksha A. Bastikar

  3. Department of Computer Aided Drug Design, Navin Saxena Research and Technology Pvt. Ltd, Gandhidham, Gujarat, India

    Alpana Bastikar

  4. Department of Pharmaceutical Chemistry, MET Institute of Pharmacy, Nashik, Maharashtra, India

    Santosh S. Chhajed

  5. Department of Pharmaceutical Chemistry, KBHSS Trust’s Institute of Pharmacy, Malegaon, Maharashtra, India

    Parag A. Pathade

Authors
  1. Pramodkumar P. Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Virupaksha A. Bastikar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alpana Bastikar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Santosh S. Chhajed
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Parag A. Pathade
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pramodkumar P. Gupta .

Editor information

Editors and Affiliations

  1. Department of Biotechnology, Institute of Biosciences and Biotechnology, Chhatrapati Shahu Ji Maharaj University, Kanpur, Uttar Pradesh, India

    Dev Bukhsh Singh

Rights and permissions

Reprints and permissions

Copyright information

© 2020 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gupta, P.P., Bastikar, V.A., Bastikar, A., Chhajed, S.S., Pathade, P.A. (2020). Computational Screening Techniques for Lead Design and Development. In: Singh, D.B. (eds) Computer-Aided Drug Design. Springer, Singapore. https://doi.org/10.1007/978-981-15-6815-2_9

Download citation

Publish with us

Policies and ethics

Search

Navigation